GlassScriptPhysician profile
David Xu
NPI 1568826519
$695.69
in general payments reported to CMS, 2019-2025
9 companies · $90.51 in 2025
The $90.51 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $140 · 2023: $313 · 2024: $152 · 2025: $90.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $435 · Education: $121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $434.74 |
| Education | $120.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $152.16 | 2024 | Direct Look |
| Genentech USA, INC. | $140.00 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $120.40 | 2023 | |
| Seagen INC. | $99.95 | 2023 | |
| Celgene Corporation | $71.67 | 2023 | Opdualag |
| Astellas Pharma Global Development | $33.10 | 2025 | Izervay |
| Harrow Eye, LLC | $28.83 | 2025 | Iheezo |
| Tempus Ai, INC | $28.58 | 2025 | Xt Cdx |
| Mirati Therapeutics, INC. | $21.00 | 2023 | Krazati |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Xu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.